1. Home
  2. KRMD vs BWAY Comparison

KRMD vs BWAY Comparison

Compare KRMD & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$3.88

Market Cap

189.3M

Sector

Health Care

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$14.91

Market Cap

674.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
BWAY
Founded
1980
2003
Country
United States
Israel
Employees
N/A
129
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.3M
674.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRMD
BWAY
Price
$3.88
$14.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$6.50
$13.25
AVG Volume (30 Days)
125.1K
133.6K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
N/A
N/A
Revenue
$41,127,366.00
N/A
Revenue This Year
$20.32
$309.69
Revenue Next Year
$17.37
$26.21
P/E Ratio
N/A
$81.98
Revenue Growth
22.23
N/A
52 Week Low
$2.63
$10.01
52 Week High
$6.61
$26.63

Technical Indicators

Market Signals
Indicator
KRMD
BWAY
Relative Strength Index (RSI) 41.93 40.14
Support Level N/A $14.56
Resistance Level $4.34 $16.63
Average True Range (ATR) 0.18 0.64
MACD -0.01 -0.19
Stochastic Oscillator 6.82 2.01

Price Performance

Historical Comparison
KRMD
BWAY

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: